Clinical Trial: Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation: a Single-arm, Open-label, Prospective Clinical Study

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483385) titled 'Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation: a Single-arm, Open-label, Prospective Clinical Study' on March 16.

Brief Summary: This study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematologic disorders.

Study Start Date: Jan. 13

Study Type: INTERVENTIONAL

Condition: Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation

Inter...